Opinions

Hope Beyond the Hype: The Pursuit of Longevity in Cell Therapies

Hope Beyond the Hype: The Pursuit of Longevity in Cell Therapies

After years of intensive research and development, cell therapies are finally having their moment. In the past year, the FDA has approved two cell therapies, with stem cell treatments in hot pursuit as they enter late-stage clinical trials. While regulatory body recognition is an important milestone, great challenges in long-term industry sustainability remain.

Permanence and Promise in Germline Engineering – Part 2

Permanence and Promise in Germline Engineering – Part 2

Part 2 of a series: The rise of genetic engineering has long provoked contentious debate within the scientific community. Stances in the scientific community on genetic engineering have become increasingly charged, as evidenced by a call for a moratorium on germline engineering research published in Nature Comments in March 2015.

Figure 1: Gene editing without double stranded breaks. Base editing system using a Cas9-cytidine deaminase fusion protein mediates guide-RNA directed C  U conversion in the target genomic sequence (from AC Komor et al. Nature. 2016, 533, 420 doi:10.1038/nature17946)

Permanence and Promise in Germline Engineering – Part1

As research in germline editing reaches new and exciting frontiers, society is prompted to decide how science can act synergistically with policy to evaluate ethical implications and advance our knowledge of genetic engineering. The following article is part one of a two part series on the science and ethics of germline engineering.

Notes from Conway’s Chair – March 2018

Notes from Conway’s Chair – March 2018

CBR research teams have been flourishing in the lab and the clinic. This is measured not only by the number and value of prestigious grants and awards received by our senior investigators and their trainees, but by the number and quality of the clinically relevant scientific advances that they have made.

When Evidence is Not Enough: Pro-Vaccination Strategies

When Evidence is Not Enough: Pro-Vaccination Strategies

Despite overwhelming evidence in favour of vaccination, immunization rates have fallen, in some areas below the thresholds necessary to protect against outbreaks of diseases. Why do people reject vaccination, and what can be done?

CIHR Fiasco… What Now?

CIHR Fiasco… What Now?

In order to reduce costs, safeguard from potential reviewer bias and guarantee a larger number of reviewers per grant, Dr. Beaudet, the current CIHR president, eliminated the face-to-face peer review and replaced it with an anonymous online system.

CRISPR Technology: Officially Off-Limits?

CRISPR Technology: Officially Off-Limits?

Some predict that there would be a series of innovation bottlenecks now that CRISPR-Cas9 is patented. Indeed, the CRISPR battle has already altered the direction of several biotechnology companies.

The Student Biotechnology Network (SBN).  Making your Biotech Goals a Reality.

The Student Biotechnology Network (SBN). Making your Biotech Goals a Reality.

Driven entirely by students and volunteers, this not-for-profit organization was founded to act as a helping hand for STEM graduates wanting to explore their career possibilities in industry.

The Quirks and Quarks of Vancouver Biotech

The Quirks and Quarks of Vancouver Biotech

While the arrival of Quark Venture promises new opportunities in the biotechnology industry, will its investments improve the longevity of biotech companies in Vancouver?

Notes from the Conway Chair…. January 2017

Notes from the Conway Chair…. January 2017

In 2017, the CBR looks to further reach out to the community, increasing awareness of the valuable work that is being done, and learning from those whom we aim to serve.